BioStock: CombiGene comments on Eurostars funding
Börskollen - Aktier, fonder och ekonominyheter
BörskollenFör dig med koll på börsen
•Spartips: Lista: 25 smarta sätt att spara pengar i vardagen – så kommer du igång

Pressmeddelande

BioStock: CombiGene comments on Eurostars funding

Cision Publicerad: 22 Dec 2023 08:57
Lärkberget

CombiGene, together with its Danish partner Zyneyro, has received welcome financial support of 8,6 million SEK from Eurostars for the continued development of the peptide COZY1, a drug candidate for the treatment of severe chronic pain conditions. BioStock reached out to CombiGene’s CEO Peter Ekolind for a comment.

Read the full interview with Peter Ekolind at biostock.se:

https://www.biostock.se/en/2023/12/combigene-comments-on-eurostars-funding/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Nyheter om Lärkberget

Läses av andra just nu

Om aktien Lärkberget

Senaste nytt